Elucid AI-PREDICT study begins testing lesion-level heart attack risk with CCTA
Elucid’s AI-PREDICT study will test whether CCTA plaque analysis can identify the coronary lesions most likely to cause a heart attack.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Conavi Medical builds case for hybrid IVUS-OCT imaging in complex PCI
Conavi Medical Corp. has announced a peer-reviewed case publication highlighting the use of its hybrid intravascular ultrasound and optical coherence tomography imaging system in a complex coronary intervention involving a patient with impaired renal function. The publication follows U.S. Food and Drug Administration 510(k) clearance for the Canadian medical device developer’s next-generation hybrid IVUS-OCT imaging
Pharma & Biotech
Ribo’s coronary artery disease filing highlights the next frontier for RNA-based cardiovascular drugs
Ribo’s RBD1119 Phase 2 filing could test whether siRNA drugs can reduce coronary artery disease risk without bleeding trade-offs.
Pharma & Biotech
How Eli Lilly and Company is positioning VERVE-102 at the center of cardiovascular gene editing
Can Eli Lilly and Company’s VERVE-102 transform cholesterol treatment through one-time gene editing? Explore the risks, data, and implications.
Medical Devices & Diagnostics
Why Abbott’s Ultreon 3.0 could reshape stent planning in complex coronary disease
AI can now guide coronary imaging in real time. Abbott’s Ultreon 3.0 puts precision PCI closer to routine clinical workflow.
Medical Devices & Diagnostics
Could Reflow Medical’s new Cora microcatheters fix a hidden pain point in complex PCI?
Find out how Reflow Medical’s Cora Flex and Cora Force launch could reshape complex coronary intervention workflows.
Medical Devices & Diagnostics
CorVista Health expands machine-learning diagnostics to INOCA with new ACC.26 poster data
CorVista Health presents machine-learned non-invasive INOCA detection data at ACC.26. Analysis of what this means for cardiology and women's heart care. Read more.
Medical Devices & Diagnostics
Can Cleerly’s AI platform replace invasive IVUS? INVICTUS registry data suggest noninvasive parity
Cleerly's INVICTUS registry shows AI-QCT matches IVUS in coronary plaque quantification. Read the clinical analysis.